Highlighted videos
QCI Interpret for Oncology
Clinician’s Roundtable: Interpreting genomic test results for precision oncology
You’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and...
QCI Interpret for Oncology
Real-World Applications of Clinical Metagenomic Sequencing in Cancer and...
Clinical metagenomic next-generation sequencing (mNGS), the comprehensive analysis of microbial and...
QIAGEN IPA
QIAGEN IPA
Single-cell RNA-seq data interpretation using QIAGEN IPA
In this webinar, the speaker will go over how to: • Identify critical...
QIAGEN IPA
‘Omics to Insights: Leveraging QIAGEN IPA for Pre-Clinical Toxicology and Safety
Pre-clinical toxicology studies generate complex datasets that require robust...
QIAGEN IPA
QIAGEN IPA New User Training
Are you new to QIAGEN Ingenuity Pathway Analysis (IPA) or interested in...
QIAGEN IPA
Investigating biomarkers with bulk and single-cell RNA-seq expression data
QIAGEN Ingenuity Pathway Analysis (IPA) is designed to help you analyze and...
QIAGEN CLC Genomics
QIAGEN CLC Genomics
Single Cell RNA-Seq and Spatial Transcriptomics
In this webinar, the speaker will cover how to simplify your single cell...
QIAGEN CLC Genomics
The increasing Accessibility of Cell Therapy, Gene Therapy, and Clinical Sequencing
Precision medicine is rapidly transforming healthcare, and one of the most...
QIAGEN CLC Genomics
Mapping the Human Body One Cell at a Time
The 37 trillion cells of the human body have a remarkable array of...
QIAGEN CLC Genomics
Single-cell RNA-seq, cell hashing and spatial transcriptomics
In this training, you will learn how to analyze and interpret your own single...
QIAGEN OmicSoft and Biomedical Knowledge Base
QIAGEN OmicSoft and Biomedical Knowledge Base
Investigate critical biological mechanisms using pathways and knowledge graphs
Pathways and knowledge graphs have provided valuable insights into disease...
QIAGEN OmicSoft and Biomedical Knowledge Base
Using OmicSoft OncoLand to integrate public expression and somatic mutation data for biomarker discovery
QIAGEN OmicSoft Lands are high-quality curated repositories of genomics and...
QIAGEN OmicSoft and Biomedical Knowledge Base
Novel discoveries utilizing public data through QIAGEN Omicsoft Lands - March 25 2021
In this 90-minute video, users will learn how to discover and validate...
日本語 (Japanese)
日本語 (Japanese)
01. QIAGEN OmicSoft チュートリアル1 概要
OmicSoft の概要と製品の種類についての説明です。
日本語 (Japanese)
02. QIAGEN OmicSoftチュートリアル2 起動と Land の選択
起動後、まず最初に利用するLand を選択します。
日本語 (Japanese)
03. QIAGEN OmicSoftチュートリアル3 グループ分け (Y軸の分類）
表示されているグラフのY軸は疾患の種類、喫煙歴等様々なメタデータで分類できます。
日本語 (Japanese)
04. QIAGEN OmicSoftチュートリアル4 遺伝子の検索、サンプルの絞り込み
単一遺伝子の検索、および様々なメタデータでサンプルの絞り込みを行う方法を解説します。
QCI Interpret for Oncology
QCI Interpret for Oncology
S2I oncology
S2I oncology
QCI Interpret for Oncology
Streamline clinical reporting for high-throughput oncology NGS testing with QCI Interpret One
With the rising demand for personalized cancer treatments, clinical...
QCI Interpret for Oncology
How to accelerate your clinical reporting workflow for high-throughput oncology NGS testing
As the demand for personalized cancer treatment grows, clinical diagnostic...
QCI Interpret for Oncology
The Implementation Journey of Comprehensive Cancer Genome Profiling and Liquid Biopsy in South East Asia
This session traces the evolution of comprehensive cancer genome profiling...
Gene Variant Databases
Gene Variant Databases
HGMD Pro in action: Search, curate and classify genetic variants - Session 1
As the use of next-generation sequencing (NGS) in diagnostics increases, so...
Gene Variant Databases
Germline and Somatic Variant Investigation using COSMIC, HGMD and QCI-IT
The accurate identification and annotation of germline and somatic variants...
Gene Variant Databases
Advances in Genomic Testing for Rare Disease Diagnostics
Over the past decade, whole-exome and whole-genome sequencing have...
Gene Variant Databases
Leveraging expert-curated knowledge from COSMIC and QIAGEN to avoid pitfalls, qualify candidate drug targets, and accelerate early discovery
The cancer drug discovery landscape is shifting. While research continues to...
QCI Interpret for Hereditary
QCI Interpret for Hereditary
Screening 100,000 newborns using whole genome sequencing: The Genomics England Generation Study
In this on-demand recording from ACMG 2024, hear from Dr. David Bick,...
QCI Interpret for Hereditary
QCI Interpret for Hereditary Disorders
Clinical labs face significant challenges in interpreting germline variants...
QCI Secondary Analysis
QCI Secondary Analysis
How decentralized and small labs can adopt high-throughput NGS analysis with limited time and resource investment
Next-generation sequencing (NGS) has rapidly gained popularity as a...
QCI Secondary Analysis
Introducing QCI Secondary Analysis
Introducing QCI Secondary Analysis, a new cloud-based service for NGS...
Pharmacogenomic Insights (PGXI)
Pharmacogenomic Insights (PGXI)
One tool to predict adverse drug reactions – Meet your new PGx powerhouse
Every year, adverse drug events affect over 134 million patients and claim...
Pharmacogenomic Insights (PGXI)
A game-changer for pharmacogenomics: One tool to decode drug response to variation in the genome
Each year, more than 134 million patients experience adverse drug events,...
Cancer Drug Discovery
Cancer Drug Discovery
Single-cell RNA-seq, cell hashing and spatial transcriptomics
In this training, you will learn how to analyze and interpret your own single...
Cancer Drug Discovery
Targeting MUC16 Neoantigens in Pancreatic Cancer: Precision Oncology and Indication Selection
This webinar shows how we enable identification and prioritization of a novel...
Cancer Drug Discovery
Data curation as a key element in successful data science strategy
Learn the 7 habits of effective manual curation that QIAGEN Digital Insights...
Cancer Drug Discovery
Exploring drug response in low-grade glioma
This webinar introduces the Tumor Microenvironment (TME) Pathway in QIAGEN’s...